·SEC EDGARLow
DEVIVO JOSEPH sold $635K of BFLY
DEVIVO JOSEPH (President & CEO) sold 90,600 shares of Butterfly Network, Inc. (BFLY) at $7.01 ($0.63M total) on 2026-10-30.
StockNYSE · US · USDHealthcare · Medical Devices
$BFLY
Butterfly Network, Inc.
Butterfly Network develops and sells portable, semiconductor-based point-of-care ultrasound devices and related software, services and educational offerings for healthcare systems, physicians, healthcare providers and veterinarians. Its handheld Butterfly iQ+ and iQ3 devices connect to mobile devices and use the Ultrasound-on-Chip platform for whole-body imaging. Its products also include the iQ+ Bladder, Butterfly Move cart system and veterinary devices. Software offerings include individual and enterprise subscriptions, Compass AI for health-system workflows, and tools for scanning, education, teleguidance and image storage. Butterfly also provides training and professional services, and licenses its semiconductor platform for co-development in noncompetitive markets through Butterfly Embedded. Butterfly sells devices, software subscriptions, services and training through direct sales, distributors and eCommerce. It is headquartered in Burlington, Massachusetts, and sells products in over 30 countries.
AlphAI earnings readThird Quarter 2026 · OCT 29Butterfly Network Reports Third Quarter 2026 Financial Results Beats High End of Quarterly Revenue and Adjusted EBITDA GuidanceVerdict: strongRead →
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Price · $BFLYvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $BFLY in the last 7 days.
Insider · 30dAll trades →
- Buys
- — 0 txs
- Sells
- $635K 1 txs
DEVIVO JOSEPH1× · $635K
10b5-1 share of filings0%
Top stories · $BFLYMore →
·quiverquant.com
$BFLY stock is down 16% today. Here's what we see in our data.
Butterfly Network (BFLY) stock fell 16% today with $32.5M in trading volume. Insiders sold 7.7M shares in 6 months, while 140 hedge funds increased holdings and 100 decreased. Notable moves include D.E. Shaw adding 6.3M shares and Bank of America reducing by 2M.
·finance.yahoo.com
Butterfly Network, Inc. Q3 2026 Earnings Call Summary
Butterfly Network reported Q3 2026 earnings, highlighting revenue growth driven by its Embedded business and U.S. enterprise contracts. International performance lagged, but the company is shifting to an institutional model. Gross margins reached 73%, and full-year guidance was raised. The company plans to launch new chips and enter the cart-based ultrasound market by 2028. A $150M ATM program was established for financial flexibility.
BFLY sentiment & insider activity
Recent BFLY coverage spans financial news, market movers and earnings.
In the last 30 days, BFLY insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($635K). The most active reporter was DEVIVO JOSEPH, President & CEO, with 1 filing.
What's driving BFLY
Insider sale may signal reduced confidence or liquidity need.
Insider sales and mixed fund flows suggest bearish sentiment, likely extending the price decline.
Guidance raise and new financing suggest upside potential, but embedded revenue remains lumpy.
Guidance raise suggests stronger near‑term growth.
Positive sentiment as the deal could drive device sales and data-driven software upgrades.
AlphAI scores every news story that mentions BFLY with an AI model for sentiment and relevance, and aggregates insider trades from Butterfly Network, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $BFLY
Score
DEVIVO JOSEPH sold $635K of BFLY
DEVIVO JOSEPH (President & CEO) sold 90,600 shares of Butterfly Network, Inc. (BFLY) at $7.01 ($0.63M total) on 2026-10-30.
$BFLY stock is down 16% today. Here's what we see in our data.
Butterfly Network (BFLY) stock fell 16% today with $32.5M in trading volume. Insiders sold 7.7M shares in 6 months, while 140 hedge funds increased holdings and 100 decreased. Notable moves include D.E. Shaw adding 6.3M shares and Bank of America reducing by 2M.
Butterfly Network, Inc. Q3 2026 Earnings Call Summary
Butterfly Network reported Q3 2026 earnings, highlighting revenue growth driven by its Embedded business and U.S. enterprise contracts. International performance lagged, but the company is shifting to an institutional model. Gross margins reached 73%, and full-year guidance was raised. The company plans to launch new chips and enter the cart-based ultrasound market by 2028. A $150M ATM program was established for financial flexibility.
Butterfly Network Reports Third Quarter 2026 Financial Results
Butterfly Network, Inc. (BFLY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Butterfly Network Reports Third Quarter 2026 Financial Results Beats High End of Quarterly Revenue and Adjusted EBITDA Guidance • Delivered quarterly Revenue of $32.6 million, driven in part by Embedded revenue • Recorded highest gross margin in Company history at 73
VCOM plans to put ultrasound devices in students' hands, with rural care in focus.
Edward Via College of Osteopathic Medicine (VCOM) and Butterfly Network (BFLY) will equip all VCOM students with Butterfly iQ3 ultrasound devices, starting with the 2026 class. The partnership aims to enhance ultrasound education and rural healthcare. BFLY will provide discounted devices and track usage through the Lighthouse Program. VCOM graduates 660 physicians annually, many serving rural areas.
2 Brain-Computer Interface Stocks to Watch While Neuralink Stays Private
Neuralink, a private brain-computer interface (BCI) company, successfully helped a patient with ALS communicate. Investors cannot buy Neuralink, but two public companies, Quantum-Si (QSI) and Butterfly Network (BFLY), are connected to the BCI field. QSI makes research tools and saw a 7x volume spike, while BFLY supplies ultrasound chips to BCI developers like Merge Labs and Bridge Neurotech.
Why is Butterfly Network stock climbing today?
Butterfly Network (BFLY) stock rose 1.6% pre-market after Canaccord Genuity initiated coverage with a Buy rating and $10 target, citing its ultrasound tech and AI capabilities. Analysts highlight new products and partnerships. The stock has seen positive analyst activity, with a consensus target of $11.40. Q3 earnings are due October 29.
Butterfly Network, Inc. (BFLY) Licenses Ultrasound Tech to Bridge for Non-Invasive BCI
Butterfly Network (BFLY) has signed a multi-year R&D and licensing deal with Bridge Neurotech. The agreement allows Bridge to use Butterfly's Ultrasound-on-Chip tech for non-invasive brain-computer interfaces. The deal includes milestone payments and hardware purchase commitments, according to the company.
Butterfly Network adds Michael Noonen to board, joins Compensation and Technology Committees
Butterfly Network (BFLY) appointed Michael Noonen to its board, effective October 9, 2026, and added him to the Compensation and Technology Committees. This increases the board size to seven directors. Noonen is independent under NYSE standards and has not previously held positions with the company.
Butterfly Network, Inc. (BFLY): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Butterfly Network, Inc. (BFLY) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Butterfly Network Appoints Mike Noonen to Board of Directors Seasoned Semiconductor Leader Brings Three Decades of Experience Scaling Chip Companies NEW YORK & BURLINGTON, Mass.-- October 5, 2026 -- Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), a pioneer and le